| Record ID | marc_columbia/Columbia-extract-20221130-011.mrc:121711843:2084 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-011.mrc:121711843:2084?format=raw |
LEADER: 02084pam a22004214a 4500
001 5268652
005 20221110004203.0
008 040728t20052005flua b 001 0 eng
010 $a 2004057042
016 7 $a101225559$2DNLM
020 $a0849314690 (alk. paper)
035 $a(OCoLC)ocm56104648
035 $a(NNC)5268652
035 $a5268652
040 $aDNLM/DLC$cDLC$dYDX$dNLM$dOrLoB-B
042 $apcc
050 00 $aRS419.5$b.M38 2005
060 00 $a2005 C-344
060 10 $aQV 744$bM434a 2005
082 00 $a615/.19$222
100 1 $aMatson, Robert S.$0http://id.loc.gov/authorities/names/n2004122416
245 10 $aApplying genomic and proteomic microarray technology in drug discovery /$cRobert S. Matson.
260 $aBoca Raton :$bCRC Press,$c[2005], ©2005.
300 $a243 pages :$billustrations (some color) ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gCh. 1.$tQuantitative biology : the "omics" era -- $gCh. 2.$tCommercial microarrays -- $gCh. 3.$tSupports and surface chemistries -- $gCh. 4.$tArraying processes -- $gCh. 5.$tGene expression : microarray-based applications -- $gCh. 6.$tProtein microarray applications.
650 0 $aHigh throughput screening (Drug development)$0http://id.loc.gov/authorities/subjects/sh2001002949
650 0 $aDNA microarrays.$0http://id.loc.gov/authorities/subjects/sh99000707
650 0 $aProtein microarrays.$0http://id.loc.gov/authorities/subjects/sh2001002930
650 0 $aPharmacogenomics.$0http://id.loc.gov/authorities/subjects/sh99000126
650 0 $aProteomics.$0http://id.loc.gov/authorities/subjects/sh2002000814
650 12 $aDrug Design.$0https://id.nlm.nih.gov/mesh/D015195
650 22 $aGenomics$xmethods.$0https://id.nlm.nih.gov/mesh/D023281Q000379
650 22 $aOligonucleotide Array Sequence Analysis$xmethods.$0https://id.nlm.nih.gov/mesh/D020411Q000379
650 22 $aProteomics$xmethods.$0https://id.nlm.nih.gov/mesh/D040901Q000379
852 00 $boff,hsl$hRS419.5$i.M38 2005